Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphomawmm2023-04-10T20:22:16-07:00March 23rd, 2023|Read more
Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptorwmm2023-04-10T20:24:04-07:00March 2nd, 2023|Read more
Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Sampleswmm2022-12-29T21:22:21-08:00November 15th, 2022|Read more
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patientswmm2022-12-29T21:19:31-08:00June 4th, 2022|Read more
Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?wmm2023-01-08T18:20:36-08:00May 30th, 2022|Read more
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in JapanInvivoscribe Marketing2023-05-25T17:09:22-07:00May 25th, 2023|Read more
Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation AssayInvivoscribe Marketing2023-05-11T03:12:47-07:00May 11th, 2023|Read more
Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in ChinaInvivoscribe Marketing2023-02-23T06:28:40-08:00February 23rd, 2023|Read more
Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)Invivoscribe Marketing2023-02-01T21:02:16-08:00February 1st, 2023|Read more
Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AMLwmm2022-10-24T14:57:12-07:00October 24th, 2022|Read more
ASH 2023December 9-12, 2023 San Diego, CA On-site Booth https://www.hematology.org/meetings/annual-meeting
EAHP-SH 2023November 9 – 11, 2023 Houston, Texas On-site Booth & Symposium https://www.society-for-hematopathology.org/2023/
JSH 2023October 13-15, 2023 Tokyo, Japan Corporate Sponsorship (symposium) http://www.jshem.or.jp/85/en/index.html